MedPath

The effect of time restricted eating on cognitive function in men with metabolic syndrome

Not Applicable
Recruiting
Conditions
Metabolic syndrome.
Metabolic syndrome
E88.81
Registration Number
IRCT20230820059191N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
40
Inclusion Criteria

Men aged between 18 and 65 years,
defined work and sleep schedule
more than 14 hours of daily intake
diagnosis of metabolic syndrome according to the International Diabetes Federation (IDF) definition
mild to moderate activity level according to the IPAQ questionnaire

Exclusion Criteria

Diabetes
thyroid disorders based on thyroid tests or thyroxine intake
eating disorders
serious diseases that affect food intake such as cancer
inability to follow a time-limited meal plan
sleep disorder diagnosed by a psychiatrist or psychologist
known disorders Psychology or psychiatry that affect the quality of sleep (anxiety, depression, stress)
use of drugs that change the quality or pattern of sleep (sedative and sleep-inducing drugs, stimulant drugs).
Drugs that take dopamine agonist drugs, procyclidine, primidone, valproic acid, olanzapine, topiramate, gabapentin, fluoxetine, sertraline, quetiapine, and trazodone.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in eating inhibition behavior resulting from go/no go test scores. Timepoint: The beginning of the study and the end of the sixth week. Method of measurement: go/nogo cognitive test.
Secondary Outcome Measures
NameTimeMethod
Changes in cognitive flexibility. Timepoint: The beginning of the study and the end of the sixth week. Method of measurement: Wisconsin cognitive Test.;Active memory changes. Timepoint: The beginning of the study and the end of the sixth week. Method of measurement: Wisconsin cognitive Test.
© Copyright 2025. All Rights Reserved by MedPath